Article

Medication Exposure and Neurodegenerative Disease Risk Across National Biobanks

2025-07-07

Abstract excerpt

Advanced age, genetics, and environmental exposures are leading contributors to the development of neurodegenerative disorders (NDD). In this study, we used data from the UK Biobank (UKB) and the All of Us (AoU) initiative to determine if exposure to specific medications are associated with an increased or decreased risk of NDD, including Alzheimer’s (AD), Parkinson’s disease (PD), and all-cause dementia (DEM). We...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: f1f18c13-2061-5992-a69a-b324a45b225e
DOI: 10.1101/2025.07.07.25330740

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Medication Exposure and Neurodegenerative Disease Risk Across National BiobanksDOI 10.1101/2025.07.07.25330740Read

Virus exposure and neurodegenerative disease risk across national biobanksSemantic proximity Read

Retrospective Case-Control Study of Pre-Diagnosis Observational and Prescription Data in Parkinson’s DiseaseSemantic proximity Read

Associations between the use of common nonsteroidal anti-inflammatory drugs, genetic susceptibility and dementia in participants with chronic pain: A prospective study based on 194,758 participants from the UK Biobank.Semantic proximity Read

Drug Repurposing for Parkinson’s Disease: A Large-Scale Multi-Cohort StudySemantic proximity Read

Longitudinal Analysis of Electronic Health Records Reveals Medical Conditions Associated with Subsequent Alzheimer’s Disease DevelopmentSemantic proximity Read

Subtyping Alzheimer's disease and Parkinson's disease using longitudinal electronic health records.Semantic proximity Read

Pharmacogenomics of Alzheimer’s and Parkinson’s diseasesSemantic proximity Read

Drug repurposing of metformin for Alzheimer’s disease: Combining causal inference in medical records data and systems pharmacology for biomarker identificationSemantic proximity Read

Identifying incident dementia by applying machine learning to a very large administrative claims datasetSemantic proximity Read

AETIONOMY, a Cross-Sectional Study Aimed at validating a new taxonomy of Neurodegenerative Diseases: Study design and subject characteristicsSemantic proximity Read

Multicomponent Mendelian randomization and machine learning studies of potential drug targets for neurodegenerative diseasesSemantic proximity Read

Association between the use of levodopa/carbidopa and the disease outcomes included in the National Alzheimer’s Coordinating Center Uniform Data SetSemantic proximity Read